Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001137050-16-000192
Filing Date
2016-01-13
Accepted
2016-01-13 11:09:06
Documents
70
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 form10ksept2015edgarized.htm 10-K 804734
2 exh311.htm EX-31 5621
3 exh312.htm EX-31 5610
4 exh321.htm EX-32 2080
5 exh322.htm EX-32 1968
  Complete submission text file 0001137050-16-000192.txt   3114988

Data Files

Seq Description Document Type Size
6 peak-20150930.xml EX-101.INS 581850
7 peak-20150930.xsd EX-101.SCH 32936
8 peak-20150930_lab.xml EX-101.LAB 168216
9 peak-20150930_pre.xml EX-101.PRE 162212
10 peak-20150930_cal.xml EX-101.CAL 6798
11 peak-20150930_def.xml EX-101.DEF 71643
Mailing Address 700 N COLORADO BLVD #734 DENVER CO 80206
Business Address 700 N COLORADO BLVD #734 DENVER CO 80206 303-415-2558
PEAK PHARMACEUTICALS, INC. (Filer) CIK: 0001452804 (see all company filings)

EIN.: 261973257 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-53855 | Film No.: 161340193
SIC: 2834 Pharmaceutical Preparations